Herman is a seasoned serial entrepreneur and technology venture expert with over 25 years of leadership experience in high-tech companies. He has successfully led and exited a number of spin-offs from the University of Leuven, including Cartagenia, which was acquired by Agilent. Following the sale, he led Agilent’s Genomics & Clinical Applications division in California. He was CEO of Biocartis, a molecular diagnostics company focused on revolutionizing personalized medicine by enabling rapid and accurate diagnostic testing.
He has a proven track record in business strategy, product development, and global commercialization. His expertise spans healthtech, medtech, AI applications, molecular techniques, genomics, multiomics, and data analytics.
